| Stockdale Podiatry Group Inc | |
|
110 New Stine Rd, Bakersfield, CA 93309-2605 | |
| (661) 832-1666 | |
| (661) 832-2039 |
| Full Name | Stockdale Podiatry Group Inc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 110 New Stine Rd, Bakersfield, California |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013013002 | NPI | - | NPPES |
| E4648 | Other | CA | LIC # HAWKINS |
| A76044 | Other | CA | LIC-MIHALUTA |
| E3008 | Other | CA | LIC-DR.HAMILTON |
| E3891 | Other | CA | LIC-DR.PASABOC |
| E3301 | Other | CA | LIC-DR.MILLER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | (California) | Primary |
| Provider Name | Mihaela Mihaluta-pasaboc |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386632834 PECOS PAC ID: 4082676648 Enrollment ID: I20041027000610 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Provider Name | Brandon James Hawkins |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1073587663 PECOS PAC ID: 8729093794 Enrollment ID: I20060213000208 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Provider Name | Liviu G Pasaboc |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1659363554 PECOS PAC ID: 0840360343 Enrollment ID: I20080609000915 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Provider Name | Thomas D Nelson |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1629093653 PECOS PAC ID: 8022168806 Enrollment ID: I20090617000199 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Provider Name | James Edwin Teela |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1932111879 PECOS PAC ID: 7012988967 Enrollment ID: I20150613000131 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Provider Name | Arsenio M Cachero |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225483514 PECOS PAC ID: 5496046674 Enrollment ID: I20160617001441 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Provider Name | Michael Clifton Mcginnis |
|---|---|
| Provider Type | Practitioner - Pathology |
| Provider Identifiers | NPI Number: 1801841358 PECOS PAC ID: 1153384169 Enrollment ID: I20161107000380 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Provider Name | Cathy Taijung Chuang Sohrabi |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1649628116 PECOS PAC ID: 4789919234 Enrollment ID: I20190705001193 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Provider Name | Kyle Huber |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1730543083 PECOS PAC ID: 5698197762 Enrollment ID: I20200617003370 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Provider Name | Michael Angel Flores |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1649839655 PECOS PAC ID: 7810221058 Enrollment ID: I20220613001836 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Provider Name | Tzu Lu Lin |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1710502414 PECOS PAC ID: 0446618060 Enrollment ID: I20230614000731 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Provider Name | Paul Myung Kim |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1700406311 PECOS PAC ID: 6305204546 Enrollment ID: I20230621001772 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Provider Name | Solomon Kim |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1346865409 PECOS PAC ID: 7517389711 Enrollment ID: I20230720002396 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stockdale Podiatry Group Inc 110 New Stine Rd, Bakersfield, CA 93309-2605 Ph: (661) 832-1666 | Stockdale Podiatry Group Inc 110 New Stine Rd, Bakersfield, CA 93309-2605 Ph: (661) 832-1666 |
News Archive
MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
A letter published today [April 8, 2021] by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013.
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times.
AbbVie, a global biopharmaceutical company, today announced new real-world data showing 96 percent of genotype 1 (GT1) patients (n=486/505 assessable for analysis) and 100 percent (n=53/53) of genotype 4 (GT4) patients achieved sustained virologic response at 12 weeks post-treatment (SVR12).
› Verified 4 days ago
Thomas D Nelson Dpm Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1701 27th St, Bakersfield, CA 93301 Phone: 661-322-2895 Fax: 661-322-2897 | |
Dr. James Francis Brown, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 110 New Stine Rd, Bakersfield, CA 93309 Phone: 661-832-1667 Fax: 661-832-7145 | |
Dr. Brandon James Hawkins, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 110 New Stine Rd, Bakersfield, CA 93309 Phone: 661-832-1667 Fax: 661-832-7145 | |
Dr. Allan Evangelista, D.P.M., M.P.H. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 110 New Stine Rd, Bakersfield, CA 93309 Phone: 661-832-1667 Fax: 661-832-7145 | |
Ali Ghorbanifarajzadeh, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 500 Old River Rd Ste 185, Bakersfield, CA 93311 Phone: 661-832-3600 Fax: 661-322-6249 | |
Carlos J. Rodriguez, DPM, MS, PA Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5020 Commerce Dr, Bakersfield, CA 93309 Phone: 661-324-4100 Fax: 661-324-4600 |